This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Study of Symptoms and Quality of Life in Patients With Implantable Cardiac Defibrillators (ICDs) and Their Caregivers

This study has been completed.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier:
NCT01454817
First received: October 14, 2011
Last updated: October 7, 2016
Last verified: October 2016
  Purpose
The purpose of this study is to better understand symptoms and quality of life in patients with heart disease and implantable defibrillators (ICDs).

Condition Intervention
Quality of Life Implantable Cardiac Defibrillators ICDs Behavioral: Quality of life

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: A Study of Symptoms and Quality of Life in Patients With ICDs and Their Caregivers

Resource links provided by NLM:


Further study details as provided by Icahn School of Medicine at Mount Sinai:

Primary Outcome Measures:
  • Physical Symptoms [ Time Frame: every 3 months plus after hospitalizations for an average of 1 year ]
    physical symptoms of pain, shortness of breath, depression, anxiety

  • Psychological Symptoms [ Time Frame: every 3 months plus after hospitalizations for an average of 1 year ]
    Psychological symptoms of anxiety and depression


Secondary Outcome Measures:
  • Quality of Life [ Time Frame: every 3 months plus after hospitalizations for an average of 1 year ]

Enrollment: 562
Study Start Date: June 2012
Study Completion Date: September 2016
Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Patients with ICDs Behavioral: Quality of life
Improving Quality of Life
Caregivers of Patients with ICDs Behavioral: Quality of life
Improving Quality of Life

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Patients:

  • Patient has an ICD
  • Age > 18
  • Fluent in English
  • Consistent and reliable access to a phone.

Caregivers of Patients:

  • Age > 18
  • Fluent in English
  • Consistent and reliable access to a phone

Exclusion Criteria:

  • Not having an ICD
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01454817

Locations
United States, Colorado
University of Colorado - Denver
Denver, Colorado, United States, 80045
United States, Connecticut
Yale New-Haven Hospital
New Haven, Connecticut, United States, 06510
United States, Minnesota
Mayo Medical Center
Rochester, Minnesota, United States, 55905
United States, New York
Montefiore Medical Center
Bronx, New York, United States, 10023
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
United States, Pennsylvania
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
Icahn School of Medicine at Mount Sinai
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Nathan Goldstein, MD Icahn School of Medicine at Mount Sinai
  More Information

Responsible Party: Icahn School of Medicine at Mount Sinai
ClinicalTrials.gov Identifier: NCT01454817     History of Changes
Other Study ID Numbers: HSM 10-00041
Study First Received: October 14, 2011
Last Updated: October 7, 2016

Keywords provided by Icahn School of Medicine at Mount Sinai:
Quality of Life
Implantable Cardiac Defibrillators
ICDs

ClinicalTrials.gov processed this record on June 28, 2017